Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From VarmX BV
Private Company Edition: The average exit from biopharma investments rose from $356.8m in 2019 to $520.6m in 2020, explaining the staggering $12bn invested in the industry during the first half of this year versus $17bn for all of last year. In recent VC deals, VelosBio’s $137m series B was the largest.
- Other Names / Subsidiaries
- Leiden University Medical Center (LUMC)